Victor M. G.
- Country
- Spain
- Department
- Oncology
Research Overview
- A Phase I/II Study of KISIMA-02 Vaccine-Based Immunotherapy in KRAS G12D/G12V Mutated Pancreatic Ductal Adenocarcinoma Patients
- Safety and Efficacy of DGKζ Inhibitor BGB-30813 and Tislelizumab in Advanced or Metastatic Solid Tumors
- Evaluation of HFB200603 Monotherapy and Combination with Tislelizumab in Patients with Advanced Solid Tumors
Data & Insights
Has run more than one trial at 146 of 253 partner sites.
Specializations
Thoracic Oncology and Precision Lung Cancer
Victor Moreno Garcia’s clinical research includes advanced and locally advanced non-small cell lung cancer, small cell lung cancer, and biomarker-defined lung malignancies such as EGFR-mutated, KRAS-altered, and HER2-driven disease.
- Advanced and resectable non-small cell lung cancer
- Small cell lung cancer
- EGFR- and KRAS-driven lung cancer
- HER2-altered thoracic tumors
His work also spans treatment-resistant thoracic tumors and lung cancer settings linked to perioperative, metastatic, and post-treatment management.
Hematologic Malignancies and Cellular Therapy
His therapeutic focus extends to acute myeloid leukemia, myelodysplastic syndromes, multiple myeloma, and diverse B-cell and T-cell lymphomas, including aggressive and relapsed or refractory forms.
- Acute myeloid leukemia
- Multiple myeloma
- Diffuse large B-cell lymphoma
- Peripheral T-cell lymphoma
He is also involved in studies of CAR-T and other immune-based approaches for blood cancers.
Genitourinary and Renal Oncology
His research landscape includes urothelial carcinoma, bladder cancer, renal cell carcinoma, and prostate cancer, with attention to advanced, metastatic, and treatment-refractory disease.
- Urothelial carcinoma
- Renal cell carcinoma
- Metastatic prostate cancer
- High-risk non-muscle invasive bladder cancer
His activity also includes upper tract urothelial disease and other solid tumors with renal or urinary tract involvement.
Digestive System Cancers and Hepatobiliary Tumors
Victor Moreno Garcia is engaged in trials across colorectal cancer, pancreatic cancer, gastric cancer, esophageal cancer, biliary tract cancer, and hepatocellular carcinoma.
- Colorectal cancer
- Pancreatic ductal adenocarcinoma
- Hepatocellular carcinoma
- Biliary tract cancer
His research also covers gastroesophageal and neuroendocrine malignancies within the broader gastrointestinal oncology field.
Solid Tumors with Immunotherapy and Molecular Targeting
His clinical interests include advanced solid tumors of the breast, ovary, head and neck, melanoma, sarcoma, and gastrointestinal stromal tumor, especially in settings defined by actionable biomarkers.
- Breast cancer
- Head and neck squamous cell carcinoma
- Ovarian cancer
- Gastrointestinal stromal tumor
He is also involved in immunotherapy-oriented and targeted approaches for advanced, metastatic, and unresectable solid malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.